IL17A and hepatocellular carcinoma: An IL‐6‐neutralizing mAb partially upregulated E‐cadherin and ZO‐1 expression and downregulated N‐cadherin and vimentin of HCC cells stimulated with IL‐17A (Figs 5A–C and S5C,D).